544 related articles for article (PubMed ID: 30143053)
1. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
[TBL] [Abstract][Full Text] [Related]
4. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma.
Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T
Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058
[TBL] [Abstract][Full Text] [Related]
5. Stem Cell Therapy of Gliomas.
Parker Kerrigan BC; Hossain A; Yamashita S; Lang FF
Prog Neurol Surg; 2018; 32():124-151. PubMed ID: 29990980
[TBL] [Abstract][Full Text] [Related]
6. Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model.
Mao J; Cao M; Zhang F; Zhang J; Duan X; Lu L; Yang Z; Zhang X; Zhu W; Zhang Q; Wang Z; Shen J
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169868
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
[TBL] [Abstract][Full Text] [Related]
8. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
10. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
11. Glioma stem cell research for the development of immunotherapy.
Xu Q; Yuan X; Yu JS
Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
[TBL] [Abstract][Full Text] [Related]
12. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-based therapy for malignant glioma.
Bexell D; Svensson A; Bengzon J
Cancer Treat Rev; 2013 Jun; 39(4):358-65. PubMed ID: 22795538
[TBL] [Abstract][Full Text] [Related]
14. The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas.
Gomes ED; Vieira de Castro J; Costa BM; Salgado AJ
Biochimie; 2018 Dec; 155():59-66. PubMed ID: 30031037
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response.
Tamura R; Tanaka T; Miyake K; Yoshida K; Sasaki H
Brain Tumor Pathol; 2017 Apr; 34(2):62-77. PubMed ID: 28386777
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
[TBL] [Abstract][Full Text] [Related]
17. In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution.
Kim SM; Jeong CH; Woo JS; Ryu CH; Lee JH; Jeun SS
Int J Nanomedicine; 2016; 11():13-23. PubMed ID: 26719691
[TBL] [Abstract][Full Text] [Related]
18. Gene Therapy and Virotherapy of Gliomas.
Kim JW; Chang AL; Kane JR; Young JS; Qiao J; Lesniak MS
Prog Neurol Surg; 2018; 32():112-123. PubMed ID: 29990979
[TBL] [Abstract][Full Text] [Related]
19. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
[TBL] [Abstract][Full Text] [Related]
20. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
